Proof-of-Concept Study of AZD4547 in Patients With FGFR1 or FGFR2 Amplified Tumours

Mise à jour : Il y a 4 ans
Référence : NCT01795768

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To assess the activity of the FGFR inhibitor AZD4547 in patients with FGFR1 or FGFR2 amplified breast, squamous lung and stomach cancer whose cancers have progressed following previous chemotherapy


Critère d'inclusion

  • Gastric Cancer,Oesophageal Cancer,Breast Cancer,Squamous cell carcinoma of the lung

Liens